Debajit Roy
Vice President, Sales and Marketing - Glenmark
Mumbai ,Maharashtra
Summary
Global Business Leader with 20+ years of experience driving growth and transformation across Dermatology, Specialty Care, Diabetes, and Cardiovascular therapies. Proven track record of building and scaling profitable businesses and consistently advancing into senior roles across leading MNCs and Large Indian companies.
Expert in business transformation, therapy shaping, and brand building—consistently delivering market beating growth in highly competitive and regulated environments. Skilled in leading large teams (470+), turning underperforming divisions into profitable business units, and cultivating strategic partnerships with global medical associations.
Known for uniting strategic vision with flawless execution to deliver sustainable growth, expand patient access, and shape therapies for long-term business impact
Overview
22
22
years of professional experience
Work History
Vice President - Gracewell Specialty and Gracemax
Glenmark Pharmaceuticals
Mumbai
07.2022 - Current
- · Leading the strategy for dermatology portfolio worth ₹250 Mn with 472 team members across sales and marketing – delivering 12% CAGR and 17% bottom line, growing 1.25X the market
- · Expanded Glenmark's dermatology portfolio within pediatric segment, improving rank from 5th to 4th position
- · Launched Glenmark Dermatology's first In-Licensing brand Jabryus (Oral Abrocitinib) in partnership with Pfizer through therapy shaping and patient centric initiatives
- · Conceptualized and executed “DOC Project” to streamline doctor dispensing system that led to saving 30 Mn promotional funds for dermatology cluster – scaled up across Glenmark India business and later adopted by 9 other companies
- · Collaborated with Indian and Global dermatologist association IADVL and AAD to launch high impact academic and patient education initiatives, strengthening advocacy and brand equity
Sr. General Manager - Gracewell Specialty and Cosm
Glenmark Pharmaceuticals
Mumbai
02.2019 - 06.2022
- · Led the BU strategy for dermatology portfolio worth ₹170 Mn with 260 team members across sales and marketing – delivering top line CAGR 9% and 29% bottom line, growing 1.3X the market
- · Driven the turnaround of Cosmocare division into profitability by portfolio expansion, product mix optimization and manpower rationalization
- · Instrumental in expanding brands like La Shield, Bontress and Hair4U into D2C channels
- · Navigated COVID Challenges to deliver top line and bottom-line growth
General Manager -Crosslands (Dermatology Division)
Sun Pharmaceuticals
Mumbai
08.2017 - 01.2019
- · Led the BU strategy for dermatology portfolio worth ₹2300 Mn with 333 team members across sales and marketing – achieved 19% topline growth with 24% EBITA growth in FY 2017-18, growing 1.4X the market
- · Strengthened antifungal portfolio by launching Fungicros and Alcros, ranked among Top XX IPM launches in India
- · Launched SAFE (Stand Against Fungal Epidemic) campaign to overcome the abuse of Steroidal combination in treating Fungal Infection
Deputy General Manager - Selecta (Biosimilars Divi
Sun Pharmaceuticals
Mumbai
09.2014 - 07.2017
- · Provided strategic leadership for Selecta, a flagship division focused on Pediatric Endocrinology, Rheumatology, and Orthopedics, with a portfolio worth ₹510 Mn and team of 60.
- · Delivered Top line growth of 41% CAGR and (14% improvement in EBITA from 6.9% to 21%) EBITA improvement from 6.9% to 21% driving portfolio expansion, product mix optimization, and margin improvement.
- · Successfully launched Infimab – the first Biosimilar of Infliximab in India, in partnership with Epirus Biopharmaceuticals US.
Sr. Manager Marketing Ranbaxy CV
Sun Pharmaceuticals
Mumbai
04.2012 - 08.2014
- · Led Marketing for ₹1600 Mn portfolio of - Statins | Anti coagulants | Anti Diabetics
- · Conceptualized nationwide 'Fit Heart Movement' with API & RSSDI, securing Guinness World Record (for -) and driving mass scale awareness of CVD prevention
- · Navigated NLEM – regulatory Price control challenge of Storvas through the high impact –Priceless campaign
- · Partnered with CSI to develop India's first lipid guidelines.
- · Flagship brands Storvas grew 1.7X the market and Division grew by 1.3x the market
Marketing Manager | Diabetes Care
Becton Dickinson
Gurgaon
08.2011 - 03.2012
- · Led the marketing initiatives of diabetes care business of Becton and Dickinson
- · Collaborated with top 14 KOLs for the development of First India Insulin Technique (FIT) guidelines
- · Strategic Partnership established with Eli Lilly, Biocon, Lupin and Sanofi Aventis for driving insulin device sales, with Biocon and Lupin being new accounts
Group Brand Manager | Ranbaxy CV
Ranbaxy Laboratories
Gurgaon
08.2009 - 07.2011
- · Responsible for Anti Diabetic portfolio of Ranbaxy CV and Launch of anti-platelet therapy Prasugrel (Prasita) in India – First Research brand of Daichi Sankyo
- · Post the merger of Ranbaxy and Daichi Sankyo, achieved 2nd rank from 9th Rank within 13 months driving consistent market share growth across key brands
Brand Manager | Sr. Brand Manager
Eli Lilly
Gurgaon
07.2007 - 07.2009
- · Responsible for Insulin and GLP 1 portfolio for Lilly India
- · Huminsulin, Lilly's first blockbuster brand, reached sales of ₹1000 Mn
- · Expanded the access of Insulin across Tier II towns through India's first contract sales force model (Pharmalink)
- · Introduced Byetta, pioneer GLP-1 therapy in India.
- · Launched ICARE & “Inspired by Diabetes” programs, building strong physician advocacy.
Territory Manager | Product Specialist | Sales Man
Eli Lilly
Nagpur
01.2004 - 07.2007
- · Promoted Lilly Diabetes Care brands as a field executive across Nepal
- · Promoted specialty brands like Xigris & Reopro for Lilly Critical Care division in central India
- · Consistently surpassed sales targets earning Lilly Star Awards for three consecutive years (2005, 2006, 2007).
Education
MBA - Marketing
Institute of Information And Management Science
Bhubaneshwar12-2004
Bachelor of Science - Science
University of Calcutta
Calcutta03-2001
Timeline
Vice President - Gracewell Specialty and Gracemax
Glenmark Pharmaceuticals
07.2022 - Current
Sr. General Manager - Gracewell Specialty and Cosm
Glenmark Pharmaceuticals
02.2019 - 06.2022
General Manager -Crosslands (Dermatology Division)
Sun Pharmaceuticals
08.2017 - 01.2019
Deputy General Manager - Selecta (Biosimilars Divi
Sun Pharmaceuticals
09.2014 - 07.2017
Sr. Manager Marketing Ranbaxy CV
Sun Pharmaceuticals
04.2012 - 08.2014
Marketing Manager | Diabetes Care
Becton Dickinson
08.2011 - 03.2012
Group Brand Manager | Ranbaxy CV
Ranbaxy Laboratories
08.2009 - 07.2011
Brand Manager | Sr. Brand Manager
Eli Lilly
07.2007 - 07.2009
Territory Manager | Product Specialist | Sales Man
Eli Lilly
01.2004 - 07.2007
MBA - Marketing
Institute of Information And Management Science
Bachelor of Science - Science
University of Calcutta
Similar Profiles
Nagaraj GowdaNagaraj Gowda
Vice President, Drug Discovery Research and Development at Ichnos Glenmark Innovation (IGI), Glenmark Pharmaceuticals Ltd.Vice President, Drug Discovery Research and Development at Ichnos Glenmark Innovation (IGI), Glenmark Pharmaceuticals Ltd.
Salma ShawkySalma Shawky
Senior PSR at GLENMARK PHARMACEUTICALSSenior PSR at GLENMARK PHARMACEUTICALS
Mukhtar SayyedMukhtar Sayyed
Senior Officer in Master Data Cell at Glenmark Pharmaceuticals Ltd.Senior Officer in Master Data Cell at Glenmark Pharmaceuticals Ltd.
ASHWITA GAJAREASHWITA GAJARE
Data Engineer at KFin Technologies Pvt. Ltd.Data Engineer at KFin Technologies Pvt. Ltd.
Anupama RamadharAnupama Ramadhar
Team Manager HRBP at Omega Healthcare Management Services Private LtdTeam Manager HRBP at Omega Healthcare Management Services Private Ltd